جست‌وجوی استاد و پژوهشگر

• Pharmacology
• Traditional Chinese Medicine
• Cancer Therapy
• +۷ مورد دیگر

Wing Lam is an Associate Research Scientist in the Department of Pharmacology at the Yale School of Medicine. He holds a BSc in Molecular Biology and a PhD in Biochemical Pharmacology from City University of Hong Kong, followed by postdoctoral training at Yale. His research focuses on developing traditional Chinese medicine (TCM) formulations as adjuvants for cancer therapy, notably YIV-906, which enhances chemotherapy efficacy and mitigates intestinal toxicity. Lam also pioneered the STAR database for herbal drug discovery and the Mechanism-Based Quality Control (MBQC) platform for botanical drug standardization. Education: BSc (Hons) Molecular Biology, City University of Hong Kong, 1995 PhD Biochemical Pharmacology, City University of Hong Kong, 1999 Postdoc, Pharmacology, Yale University, 1999-2002 His research interests span cancer pharmacology, TCM modernization, and mitochondrial toxicity mechanisms. Key projects include YIV-906’s role in enhancing anti-PD1 and CAR T-cell therapies, developing L-nucleoside analogs like troxacitabine, and investigating tylophorine analogs’ antitumor effects. Lam has co-chaired sessions at multiple Consortium for Globalization of Chinese Medicine (CGCM) meetings and contributed to patents on herbal drug formulations and quality control methods. Recent work explores YIV-906’s potential for inflammatory bowel disease (IBD) and phase II clinical trials for colon and liver cancers. Lam’s publications highlight synergistic drug interactions, mitochondrial DNA depletion mechanisms, and TCM’s evidence-based application in chronic diseases. His grants include studies on PHY906 as an adjuvant in rectal cancer therapy and collaborations with Yiviva, Inc. He maintains active roles in editorial boards, including a special issue on herbal drug quality control in Frontiers in Pharmacology . Lam’s lab is embedded within Dr. Yung-Chi Cheng’s group, focusing on translational pharmacology and botanical drug innovation.

Kelly Arnoldمشاهده پروفایل

دانشیار

• Biomedical Computation and Modeling
• Drug Delivery and Therapeutics
• Systems Immunology
• +۵ مورد دیگر

Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.

• Microbiology
• Infectious Diseases
• Cell Biology
• +۷ مورد دیگر

Manuel R. Amieva is a Professor at Stanford University School of Medicine , holding joint appointments in Pediatrics - Infectious Diseases and Microbiology & Immunology . He is also a member of the Maternal & Child Health Research Institute (MCHRI) . His clinical practice at Stanford Medicine Children's Health focuses on pediatric infectious diseases. Education: Medical Education: Stanford University School of Medicine (1997) Fellowship: Stanford University Pediatric Infectious Disease Fellowship (2004) Internship & Residency: Stanford Health Care at Lucile Packard Children's Hospital (1998-1999) Dr. Amieva's research investigates host-pathogen interactions at epithelial barriers, with specific expertise in Helicobacter pylori , Listeria monocytogenes , Salmonella enterica , and Staphylococcus aureus . His lab develops innovative organoid culture systems with controlled polarity to study microbial colonization and oncogenic mechanisms. Key discoveries include: H. pylori's manipulation of epithelial junctions via the CagA protein Listeria's exploitation of cell extrusion sites for invasion Staphylococcus toxin interactions with adherens junctions Gastric stem cell activation by pathogens Recent publication trends show continued leadership in infectious disease mechanisms (2020-2025), with a focus on: Pathogen-specific epithelial breach strategies Organoid modeling of viral/bacterial interactions Redox-dependent host factor regulation Single-cell spatial transcriptomic analyses Multi-institutional educational frameworks His scientific collaborations span disciplines including: Gastric cancer genomics initiatives COVID-19 lung infection models Stem cell-microbe interactions Medical education reform projects Dr. Amieva maintains active clinical research while mentoring students in both the Microbiology & Immunology and Pediatrics programs. His lab at Stanford employs advanced 3D confocal microscopy and organ-on-a-chip technologies to visualize epithelial colonization dynamics.

• Nanomedicine
• Therapeutic Targeting
• Drug Delivery Systems
• +۴ مورد دیگر

Dr. Susan Hua is an Associate Professor at the University of Newcastle's School of Biomedical Sciences and Pharmacy, specializing in translational nanopharmaceutics and therapeutic targeting. She established the first translational nanopharmaceutics laboratory in the Hunter region, focusing on drug delivery systems for gastrointestinal, musculoskeletal, and reproductive pathologies. Education: Bachelor of Pharmacy with Honours, University of Queensland (UQ) PhD in Neuroscience and Nanotechnology, UQ Research Interests: Her work centers on using nanotechnology to create targeted drug delivery systems for diseases such as chronic pain, inflammatory conditions, and obstetric complications. Key focuses include oxytocin receptor-targeted liposomes for uterine therapies and localized drug delivery to bypass biological barriers. Awards & Recognition: 2020 DVC(A) Educator Innovation Award 2017 NSW Premier's Early Career Researcher of the Year 2015 HMRI Early Career Researcher of the Year Grants & Collaborations: A/Prof Hua has secured over $5.5M in grants, including NHMRC and ARC funding. She collaborates with institutions like HMRI, John Hunter Hospital, and global teams on projects like nanoparticle-based treatments for preterm labor and uterine hemorrhage. Teaching & Leadership: She coordinates pharmacy programs, emphasizing clinical application and innovation. Her courses include Pharmacotherapeutics and Pharmacy Practice, with awards for teaching excellence (2020, 2011). Labs & Programs: Head of Therapeutic Targeting Program, University of Newcastle Director, Translational Pharmaceutics & Medical Technologies Theme (HMRI)

• Radiation Biology
• Radiation Carcinogenesis
• Radiation Applications in Medicine
• +۳ مورد دیگر

John Ford is an Associate Professor in the Department of Nuclear Engineering at Texas A&M University. His research focuses on radiobiology, radiation carcinogenesis, and medical applications of radiation. He holds academic appointments within the College of Engineering and contributes to the Health Physics, Radiation Biology & Medical Physics research group. Education includes a B.S. and M.S. in Nuclear Engineering from Mississippi State University (1982, 1986), a Ph.D. in Biomedical Sciences from the University of Tennessee (1992), and postdoctoral training at Oak Ridge National Laboratory (1992–1993). His work emphasizes understanding radiation effects on biological systems, with notable contributions to radiation dosimetry, bystander signaling mechanisms, and dietary modulation of radiation damage. Recent studies explore space radiation monitoring technologies and therapeutic applications of radiation. Awards include the BP Award for Teaching Excellence (2007) and ARRO Educator of the Year (2013–2014). Research spans interdisciplinary areas such as radiation-induced cancer mechanisms, nutritional interventions to mitigate radiation effects, and advanced radiation detection instrumentation. He has advised numerous projects in radiation safety curriculum development and collaborated on NASA-funded studies modeling radiation impacts on astronauts.

• Computational Pathology
• Medical Image Analysis
• Deep Learning
• +۴ مورد دیگر

Nasir M. Rajpoot is a Professor in the Department of Computer Science at the University of Warwick, UK. His research focuses on computational pathology, medical image analysis, and deep learning applications in histology. He leads interdisciplinary projects integrating artificial intelligence with healthcare, particularly in cancer diagnostics and pathology workflows. Rajpoot’s work emphasizes developing robust algorithms for histology image analysis, including nuclear segmentation, tumor classification, and domain generalization in computational pathology. His contributions include the TIAToolbox, an open-source framework for tissue image analytics, and the CoNIC Challenge to advance nuclear detection and counting in histology images. He collaborates with clinicians and biologists to translate AI models into clinical practice, addressing challenges like tumor heterogeneity and staining variability. Rajpoot’s research spans colorectal, lung, and oral cancers, with a focus on predicting clinical outcomes via histological features and genomic data integration. Notable projects include the development of Handcrafted Histological Transformer (H2T) for unsupervised representations of whole slide images and the SAFRON framework for histology image synthesis. His work addresses domain adaptation, robustness evaluation, and explainability in AI-driven pathology systems.

• General Surgery
• Colorectal Surgery
• Endometriosis Surgery
• +۳ مورد دیگر

Dr. Joseph Choi is a Clinical Lecturer and General Surgery Fellow at the University of Sydney's Westmead Clinical School, within the Discipline of Surgery under the Faculty of Medicine and Health. He holds academic qualifications including BSc(Adv), MBBS, MPhil, and FRACS. His clinical and research interests focus on surgical outcomes, colorectal surgery, endometriosis management, and minimally invasive techniques. Dr. Choi's research emphasizes surgical complications, anastomotic leak prediction, and emerging surgical technologies. He has contributed to over 30 peer-reviewed publications since 2011, with recent work addressing robotic surgery feasibility, Strongyloides stercoralis infections, and HER2 therapy outcomes in breast cancer. His academic profile includes collaborations with multidisciplinary teams across oncology, gastroenterology, and gynecology. No formal awards or grants are explicitly listed, though his prolific publication record reflects sustained scholarly activity.

Mahdi S. Hosseiniمشاهده پروفایل

استادیار

• Deep Learning
• Computer Vision
• Computational Pathology
• +۳ مورد دیگر

Mahdi S. Hosseini is an Assistant Professor in the Department of Computer Science and Software Engineering at Concordia University and a faculty member of the Applied AI Institute. He holds a PhD from the University of Toronto (2016) and completed a postdoctoral fellowship at UofT, supported by MITACS-Elevate and NSERC fellowships. His research focuses on advancing deep learning and computer vision for computational pathology and healthcare technologies, aiming to develop AI tools for clinical diagnosis. He currently supervises graduate students and has published over 30 papers and two patents. Education: PhD in Electrical and Computer Engineering from the University of Toronto (2016), postdoctoral training at UofT collaborating with Huron Digital Pathology Inc. (Waterloo, Ontario). Research interests include deep learning, computer vision, computational pathology, medical imaging, and AI ethics (P4AI project). His work emphasizes developing explainable AI systems for clinical pathology, biomarker discovery, and efficient learning algorithms. Professional service includes serving as Area Chair for NeurIPS 2023, CVPR 2023-2024, and ECCV 2024. He reviews grants for CIHR, NSERC, and serves on program committees for key conferences (ICCV, CVPR, NeurIPS). Teaching includes courses on applied AI, machine learning, and deep learning for computational pathology at both graduate and undergraduate levels. Awards: MITACS-Elevate Fellowship (postdoc), NSERC Research Funding (2016-2017). His work has led to patents in diagnostic systems and has collaborated with hospitals and pathologists to advance clinical applications. Labs/Teams: Active collaborations with the Applied AI Institute at Concordia, Huron Digital Pathology, and healthcare institutions. Research emphasizes interdisciplinary approaches between computer science and clinical medicine.

• Mucosal Immunology
• Intestinal Microbiota
• Host-Immune System Interaction
• +۳ مورد دیگر

Dame Fiona Powrie is a Professor of Musculoskeletal Sciences at the University of Oxford and Director of the Kennedy Institute of Rheumatology . She leads the Mucosal Immunology Research Group and serves as Director of the Oxford Centre for Microbiome Studies (OCMS) and Cluster Lead in the MRC National Mouse Genetics Network Microbiome Cluster . Roles: Director of Kennedy Institute, Professor, Research Group Leader Relevant Affiliations: Wellcome Trust Governor (2018–present), Deputy Chair (2022), Royal Society Fellow (2011) Research Interests : Fiona specializes in the interplay between the intestinal microbiota and the host immune system, focusing on how dysregulation leads to inflammatory bowel disease (IBD) . Her work has elucidated the role of regulatory T cells in maintaining gut homeostasis and identified the IL-23 pathway as critical in chronic intestinal inflammation. Current efforts aim to translate these findings into clinical therapies for IBD patients. Scientific Awards and Fellowships : Ita Askonas Award (European Federation of Immunological Societies) Louis-Jeantet Prize for Medicine (2012) Honorary Lifetime Membership (British Society of Immunology, 2021) Fellow of the Royal Society (2011), EMBO (2013), Academy of Medical Sciences (2014) International Fellow of the National Academy of Sciences (2020) Advising and Leadership : Fiona leads the Mucosal Immunology group at the Kennedy Institute, mentors researchers, and contributes to national and international scientific governance. She has been instrumental in advancing microbiome and immunology research through leadership roles at the Oxford Centre for Microbiome Studies and the MRC National Mouse Genetics Network . Labs and Teams : Fiona's research group at the Kennedy Institute of Rheumatology investigates mucosal immunity and microbiome interactions, combining experimental and clinical approaches to address inflammatory diseases.

Philipp Neumannمشاهده پروفایل

استاد

• High-Performance Computing
• Scientific Computing
• Parallel and Distributed Systems
• +۴ مورد دیگر

Philipp Neumann is a Professor and Chair of High-Performance Computing at Helmut Schmidt University since 2019. Previously, he held roles including Senior Researcher at the German Climate Computing Center (2016–2019), Postdoc at the University of Hamburg (2017–2019), and completed his Habilitation in Scientific Computing at TU Munich (2019). He transitioned to DESY/Universität Hamburg in May 2024. Education : PhD (Dr. rer. nat.) in Scientific Computing at TU Munich (2008–2013) Habilitation in Scientific Computing at TU Munich (2019) Studies in Technomathematics at Friedrich-Alexander University Erlangen-Nuremberg (2003–2008) Research Interests focus on high-performance computing, parallel and distributed systems, computational science, and applications in climate modeling. His work bridges computational methods with medical challenges, including surgical simulation training, wound healing mechanisms, and gastrointestinal pathology. Professional Activities include leadership roles in major conferences such as steering committee member for ISPDC (since 2021) and program committee roles in IPDPS, ICCS, and IEEE Cluster. He also managed the DFG priority program SPPEXA (2013–2016). Labs/Teams include the Chair for High-Performance Computing at Helmut Schmidt University and collaborations with the German Climate Computing Center. His current work at DESY/Universität Hamburg likely expands these computational efforts into interdisciplinary research.

• Equine Internal Medicine
• Equine Digestive Diseases
• Infectious Diseases in Horses
• +۶ مورد دیگر

Lieuwke Kranenburg is an Assistant Professor at the Faculty of Veterinary Medicine , Utrecht University , specializing in Equine Internal Medicine . She provides patient care at the University Equine Clinic and teaches Master's courses in equine digestion , infectious diseases , and skin problems . Research Focus: Equine internal medicine, digestive diseases, infectious pathogens, metabolic disorders Professional Certifications: EBVS® European Veterinary Specialist in Equine Internal Medicine International Collaboration: Trained Chinese veterinarians at Heilan Equestrian Centre Publications highlight her work on equine gastric disease management, diagnostic imaging, infectious disease epidemiology, and metabolic research. She contributes to equine clinical research through peer-reviewed journals and conference abstracts. Professional Involvement: Former board member of the Equine Medicine Group and current GGP representative for FEEVA, maintaining professional networks and advancing equine veterinary practice.

• Oncology
• HIV/AIDS and Cancer
• Medical Informatics
• +۴ مورد دیگر

Roxanne Wadia, MD, holds dual roles as a Clinical Fellow in Pathology and Clinical Assistant Professor of Medicine (Medical Oncology) at Yale School of Medicine. Her expertise spans anatomic and cytopathology, with a focus on cancer diagnosis and treatment guidance. She completed her medical degree at Vanderbilt University School of Medicine (2008) and is board-certified in Anatomic Pathology (2023) and Cytopathology (2024). Dr. Wadia’s research integrates oncology, HIV/AIDS, and medical informatics, leveraging large datasets such as the VA’s Million Veterans Program to improve cancer care outcomes. She actively contributes to clinical care at Yale New Haven Hospital, the VA Connecticut Healthcare System, and the Hospital of Saint Raphael’s, emphasizing holistic patient care and interdisciplinary collaboration. Her research explores prostate cancer prognosis, HIV-related malignancies, and healthcare analytics. Key projects include developing predictive tools for nonmetastatic prostate cancer mortality and studying lung cancer surgery outcomes in HIV-positive patients. Dr. Wadia also mentors trainees in oncology and hematology, emphasizing independent clinical decision-making. She participates in the VA’s clinical training programs for medical students, residents, and fellows, fostering a balance between clinical practice and research innovation.

• Medical Image Reconstruction
• Computed Tomography
• Positron Emission Tomography
• +۶ مورد دیگر

Professor Jerome Liang is a distinguished faculty member at Stony Brook University's Renaissance School of Medicine, holding professorships in Radiology, Biomedical Engineering, Electrical and Computer Engineering, and Computer Science. He serves as Co-Director of Radiology Research and has established himself as a leading expert in medical imaging reconstruction techniques. Dr. Liang's educational background includes a Ph.D. in Physics from City University of New York, postdoctoral training at Duke University, and fellowship at Albert Einstein College of Medicine. His undergraduate degree in Modern Physics was obtained from Lanzhou University in China. His primary research interests focus on advanced medical imaging techniques, particularly low-dose computed tomography image reconstruction, quantitative SPECT reconstruction, high-resolution PET imaging, tissue segmentation from multi-spectral images, computer-aided diagnosis systems, and virtual colonoscopy development. His work bridges engineering principles with clinical applications to improve diagnostic imaging capabilities while reducing radiation exposure. Analysis of his recent publications reveals a strong focus on machine learning applications in medical imaging, particularly in polyp classification, dual-energy CT spectral analysis, and virtual endoscopy. His research consistently aims to enhance diagnostic accuracy while optimizing radiation dose and improving visualization techniques for various medical conditions. 1981 China-US Physics Examination and Application Program (CUSPEA) Winner (Top 25 among 250,000 candidates) 1990 NIH First Investigator Award 1996 American Heart Association Established Investigator Award 1996 Radiological Society of North America Certificate of Merit Award 2002 SUNY Chancellor's Entrepreneur Award 2007 IEEE Society Fellow 2011-2013 SBU, BNL and CSHL Certificates of Excellence in Research and Invention 2013 Stony Brook School of Medicine Award for Excellence in Translational Research Dr. Liang has secured significant research funding including NIH/NCI R01 grants for "Advanced Virtual Colonoscopy for Early Cancer Screening" and "Radiogenomics of Colorectal Polyps." He currently leads active protocols including IRB 93995-MODCR005 focused on integrating virtual and optical colonoscopies with pathological analysis. His laboratory (IRIS - Imaging Research and Informatics) continues to advance medical imaging technology while mentoring the next generation of researchers in this critical field.

• Gastrointestinal Pathology
• Inflammatory Bowel Disease
• Colorectal Carcinoma
• +۷ مورد دیگر

Lindsay Alpert is an Associate Professor in the Department of Pathology at the University of Chicago's Pritzker School of Medicine. As a surgical pathologist specializing in gastrointestinal pathology, Dr. Alpert provides expert diagnostic services for neoplastic and non-neoplastic diseases of the gastrointestinal tract, biliary tree, and pancreas. Dr. Alpert received her MD from Columbia University College of Physicians and Surgeons in 2012. She completed her residency in Anatomic Pathology and fellowship in Gastrointestinal and Hepatic Pathology at the University of Chicago, finishing her fellowship in 2016 and residency in 2017. Dr. Alpert's research focuses on gastrointestinal pathology with particular expertise in inflammatory bowel disease, colorectal carcinoma, and the gut microbiome. Her work examines dysplasia patterns in IBD patients, histologic features of enteropathies, and the impact of therapeutic interventions on gastrointestinal tissues. She has made significant contributions to understanding the histologic spectrum of various gastrointestinal conditions and their clinical implications, with numerous publications in high-impact journals like Modern Pathology and Gastroenterology. Analysis of Dr. Alpert's recent publications reveals a strong focus on gastrointestinal pathology, particularly inflammatory bowel disease and colorectal neoplasia. Her work spans diagnostic pathology, molecular characterization of gastrointestinal tumors, and the impact of therapeutic interventions. Many studies examine dysplasia patterns in IBD patients across different age groups and presentations, while others investigate rare gastrointestinal conditions and their histologic features. Her research often bridges basic science with clinical applications, examining how dietary and pharmacological factors influence gastrointestinal pathology. Dr. Alpert actively collaborates with numerous researchers and clinicians at the University of Chicago and beyond, contributing to multidisciplinary studies that bridge pathology with clinical gastroenterology and oncology. Her network includes prominent colleagues such as John Hart, Namrata Setia, and Shu-Yuan Xiao. Dr. Alpert maintains an active research laboratory focused on gastrointestinal pathology, where she mentors trainees and collaborates with colleagues on various research projects examining the histopathology of gastrointestinal diseases. Her team works closely with clinicians to translate pathological findings into improved diagnostic criteria and patient care, particularly for complex cases involving inflammatory bowel disease and gastrointestinal neoplasia.

Sophie Lanoneمشاهده پروفایل

پژوهشگر

• Genetic-Environment Interactions
• Cystic Fibrosis
• Respiratory Pathologies
• +۳ مورد دیگر

Sophie Lanone is a researcher and team leader of the Genetic-environment Interactions in COPD, Cystic Fibrosis, and Respiratory Pathologies (GEIC2O) team at the Mondor Institute of Biomedical Research (IMRB), affiliated with Université Paris-Est Créteil. Her work focuses on understanding the interplay between genetic and environmental factors in respiratory diseases, particularly COPD, cystic fibrosis, and surfactant-related pathologies. She leads a multidisciplinary team of clinicians and scientists investigating molecular mechanisms, inflammation resolution, and environmental impacts on pulmonary health. Key research themes include the molecular basis of cigarette smoke-induced COPD, genetic and cellular aspects of cystic fibrosis, and the role of specialized pro-resolving mediators in disease. Funding sources include EU programs (e.g., H2020 REMEDIA), ANR, and patient associations like Vaincre la Mucoviscidose. Recent advances include identifying lipid mediator defects in CF patients and demonstrating resolvin E1’s efficacy in correcting ciliary dysfunction. Team members have received awards, such as Khadeeja Adam Sy’s 2024 prize for active participation in CF research. Collaborations span in vitro/ex vivo models, patient cohort studies, and translational approaches toward personalized therapies. The team also explores environmental exposures (e.g., asbestos, nanoparticles) and their long-term respiratory health impacts.